|
|
| Vitamines - Compléments Alimentaires > Etude de marché sectorielle |
| OTC Healthcare in Uruguay to 2010 |
|
|
|
|
€ 396,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Février 2007 |
Taille du document : |
149 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Vitamins 773 pages | Août 2005 |
This report analyzes the worldwide markets for Vitamins in Millions of US$. The specific product segments analyzed are Vitamin A, Vitamin D, Vitamin E, Vitamin K, Vitamin B Complex, and Vitamin C.< |
3 091,00 €
|
| |
| |
Herbal Supplements and Remedies 315 pages | Août 2006 |
This report analyzes the worldwide markets for Herbal Supplements and Remedies in Millions of US$. The Major product segments analyzed are Ginkgo Biloba, Garlic, Ginseng, Echinacea, St. John's W |
3 160,00 €
|
| |
| |
Chinese Markets for Vitamins and Supplements 165 pages | Janvier 2002 |
China's demand for vitamins and supplements has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's |
2 835,00 €
|
| |
| |
World Nutraceuticals 486 pages | Juillet 2006 |
This comprehensive study analyzes the world market for nutraceuticals. Nutraceuticals are defined as bulk chemical ingredients which increase the health or nutritional benefits of end-use products |
4 400,00 €
|
| |
| |
Key Trends in Nutraceutical Food and Drinks: Novel ingredients, new applications and future revenue opportunities 254 pages | Janvier 2007 |
As the global population ages, fast foods become more prevalent and distrust of traditional pharmaceuticals grows, the pressure on the food and drinks industry to provide cost effective solutions for |
1 528,00 €
|
| |
| |
U.S. Vitamin and Minerals Market Sales, 2005-2012 1 pages | Octobre 2006 |
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Nutraceuticals in Europe 17 pages | Novembre 2004 |
Datamonitor's Nutraceuticals in Europe industry profile is an essential resource for top-level data and analysis covering the nutraceuticals industry. It includes data on market size and segmentati |
160,00 €
|
| |
| |
Nutraceuticals in Germany 18 pages | Novembre 2004 |
Datamonitor's Nutraceuticals in Germany industry profile is an essential resource for top-level data and analysis covering the nutraceuticals industry. It includes data on market size and segmentat |
160,00 €
|
| |
| |
State Market Index: Dietary supplements, dairy and non-dairy based - Manufacturing 12 pages | Juillet 2006 |
The metrics in this report cover three year trends in Dietary supplements, dairy and non-dairy based [Manufacturing sector], broken out on a state-by-state basis. Analysis is based on data applied |
475,00 €
|
| |
| |
OTC Vitamins and Dietary Supplements in the United Kingdom 10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Vitamins and Dietary Supplements in the UK' Major Market Profile report offers an introduction to the market. It is c. 10 pages long and provides a top line ove |
198,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Healthcare in Uruguay to 2010 |
|
|
Introduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in Uruguay. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2005 and full forecasts to 2010.
Scope
Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products.Provides market value, volume, expenditure and consumption data by market, segment and subsegment.Includes company and brand share data by category, as well as distribution channel data.Contains market value segmentation by demographic group.
Highlights
The market for OTC Healthcare in Uruguay increased between 2000-2005, growing at an average annual rate of 2.8%.
The leading company in the market in 2005 was GlaxoSmithKline Plc. The second-largest player was Pfizer Inc with Avon Products, Inc. in third place.
Reasons to Purchase
Discover the major quantitative trends affecting the OTC Healthcare markets.Understand consumers' consumption and expenditure patterns.Understand the future direction of the market with reliable historical data and full five year forecasting.
|
|
CHAPTER 1 INTRODUCTION 20 What is this report about? 20 How to use this report 20 Definitions 20 CHAPTER 2 URUGUAY OTC HEALTHCARE 25 2.1 Value 25 2.2 Market Share 33 2.3 Distribution 36 2.4 Expenditure & consumption per head 37 2.5 ConsumerGraphics 41 CHAPTER 3 URUGUAY ANALGESICS 44 3.1 Value 44 3.2 Market Share 49 3.3 Distribution 51 3.4 Expenditure & consumption per head 52 3.5 ConsumerGraphics 54 CHAPTER 4 URUGUAY COUGH AND COLD PREPARATIONS 57 4.1 Value 57 4.2 Market Share 63 4.3 Distribution 65 4.4 Expenditure & consumption per head 66 4.5 ConsumerGraphics 69 CHAPTER 5 URUGUAY INDIGESTION PREPARATIONS 72 5.1 Value 72 5.2 Market Share 77 5.3 Distribution 79 5.4 Expenditure & consumption per head 80 5.5 ConsumerGraphics 82 CHAPTER 6 URUGUAY MEDICATED SKIN PRODUCTS 85 6.1 Value 85 6.2 Market Share 91 6.3 Distribution 93 6.4 Expenditure & consumption per head 94 6.5 ConsumerGraphics 97 CHAPTER 7 URUGUAY TRADITIONAL MEDICINES 100 7.1 Value 100 7.2 Market Share 104 7.3 Distribution 106 7.4 Expenditure & consumption per head 107 7.5 ConsumerGraphics 109 CHAPTER 8 URUGUAY VITAMINS AND MINERALS 112 8.1 Value 112 8.2 Market Share 118 8.3 Distribution 120 8.4 Expenditure & consumption per head 121 8.5 ConsumerGraphics 123 CHAPTER 9 URUGUAY OTHER OTC HEALTHCARE 126 9.1 Value 126 9.2 Market Share 130 9.3 Distribution 132 9.4 Expenditure & consumption per head 133 9.5 ConsumerGraphics 135 CHAPTER 10 URUGUAY MACROECONOMIC PROFILE 138 10.1 Macroeconomic Indicators 138 CHAPTER 11 RESEARCH METHODOLOGY 144 11.1 Methodology overview 144 11.2 Secondary research 145 11.3 Market modelling 146 Creating an initial data model 146 Revising the initial data model 146 Creating a final estimate 147 Creating demographic value splits 147 11.4 Primary research 147 11.5 Data finalisation 148 11.6 Ongoing research 148 CHAPTER 12 APPENDIX 149 12.1 Future readings 149 12.2 How to contact experts in your industry 149 List of Tables Table 1: OTC Healthcare category definitions 21 Table 2: OTC Healthcare distribution channels 23 Table 3: Uruguay OTC Healthcare value, 2000-2005 (UYU m, 2005 prices) 25 Table 4: Uruguay OTC Healthcare value forecast, 2005-2010 (UYU m, 2005 prices) 26 Table 5: Uruguay OTC Healthcare value, 2000-2005 (UYU m, nominal prices) 28 Table 6: Uruguay OTC Healthcare value forecast, 2005-2010 (UYU m, nominal prices) 29 Table 7: Uruguay OTC Healthcare value, 2000-2005 (US$ m nominal prices) 30 Table 8: Uruguay OTC Healthcare value forecast, 2005-2010 (US$ m nominal prices) 31 Table 9: Uruguay OTC Healthcare brand share, by value, 2004-2005 (%) 33 Table 10: Uruguay OTC Healthcare value, by brand, 2004-2005 (UYU m nominal prices 34 Table 11: Uruguay OTC Healthcare company share, by value, 2004-2005 (%) 35 Table 12: Uruguay OTC Healthcare value, by company, 2004-2005 (UYU m nominal prices) 35 Table 13: Uruguay OTC Healthcare distribution channels, by value, 2004-2005 (%) 36 Table 14: Uruguay OTC Healthcare value, by distribution channel, 2004-2005 (UYU m nominal prices) 36 Table 15: Uruguay OTC Healthcare expenditure per head, 2000-2005 (UYU, 2005 prices) 37 Table 16: Uruguay OTC Healthcare forecast expenditure per head, 2005-2010 (UYU, 2005 prices) 38 Table 17: Uruguay OTC Healthcare expenditure per head, 2000-2005 (US$ nominal prices) 39 Table 18: Uruguay OTC Healthcare forecast expenditure per head, 2005-2010 (US$ nominal prices) 40 Table 19: Uruguay OTC Healthcare value, by age group, 2005 41 Table 20: Uruguay OTC Healthcare value, by income group, 2005 41 Table 21: Uruguay OTC Healthcare value, by gender, 2005 42 Table 22: Uruguay OTC Healthcare value, by marital status, 2005 42 Table 23: Uruguay OTC Healthcare value, by size of household, 2005 43 Table 24: Uruguay OTC Healthcare value, by urban/rural residence, 2005 43 Table 25: Uruguay Analgesics value, 2000-2005 (UYU m, 2005 prices) 44 Table 26: Uruguay Analgesics value forecast, 2005-2010 (UYU m, 2005 prices) 44 Table 27: Uruguay Analgesics value, 2000-2005 (UYU m, nominal prices) 46 Table 28: Uruguay Analgesics value forecast, 2005-2010 (UYU m, nominal prices) 46 Table 29: Uruguay Analgesics value, 2000-2005 (US$ m nominal prices) 47 Table 30: Uruguay Analgesics value forecast, 2005-2010 (US$ m nominal prices) 47 Table 31: Uruguay Analgesics brand share, by value, 2004-2005 (%) 49 Table 32: Uruguay Analgesics value, by brand, 2004-2005 (UYU m nominal prices) 49 Table 33: Uruguay Analgesics company share, by value, 2004-2005 (%) 50 Table 34: Uruguay Analgesics value, by company, 2004-2005 (UYU m nominal prices) 50 Table 35: Uruguay Analgesics distribution channels, by value, 2004-2005 (%) 51 Table 36: Uruguay Analgesics value, by distribution channel, 2004-2005 (UYU m nominal prices) 51 Table 37: Uruguay Analgesics expenditure per head, 2000-2005 (UYU, 2005 prices) 52 Table 38: Uruguay Analgesics forecast expenditure per head, 2005-2010 (UYU, 2005 prices) 52 Table 39: Uruguay Analgesics expenditure per head, 2000-2005 (US$ nominal prices) 53 Table 40: Uruguay Analgesics forecast expenditure per head, 2005-2010 (US$ nominal prices) 53 Table 41: Uruguay Analgesics value, by age group, 2005 54 Table 42: Uruguay Analgesics value, by income group, 2005 54 Table 43: Uruguay Analgesics value, by gender, 2005 55 Table 44: Uruguay Analgesics value, by marital status, 2005 55 Table 45: Uruguay Analgesics value, by size of household, 2005 56 Table 46: Uruguay Analgesics value, by urban/rural residence, 2005 56 Table 47: Uruguay Cough and cold preparations value, 2000-2005 (UYU m, 2005 prices) 57 Table 48: Uruguay Cough and cold preparations value forecast, 2005-2010 (UYU m, 2005 prices) 58 Table 49: Uruguay Cough and cold preparations value, 2000-2005 (UYU m, nominal prices) 60 Table 50: Uruguay Cough and cold preparations value forecast, 2005-2010 (UYU m, nominal prices) 60 Table 51: Uruguay Cough and cold preparations value, 2000-2005 (US$ m nominal prices) 61 Table 52: Uruguay Cough and cold preparations value forecast, 2005-2010 (US$ m nominal prices) 61 Table 53: Uruguay Cough and cold preparations brand share, by value, 2004-2005 (%) 63 Table 54: Uruguay Cough and cold preparations value, by brand, 2004-2005 (UYU m nominal prices) 63 Table 55: Uruguay Cough and cold preparations company share, by value, 2004-2005 (%) 64 Table 56: Uruguay Cough and cold preparations value, by company, 2004-2005 (UYU m nominal prices) 64 Table 57: Uruguay Cough and cold preparations distribution channels, by value, 2004-2005 (%) 65 Table 58: Uruguay Cough and cold preparations value, by distribution channel, 2004-2005 (UYU m nominal prices) 65 Table 59: Uruguay Cough and cold preparations expenditure per head, 2000-2005 (UYU, 2005 prices) 66 Table 60: Uruguay Cough and cold preparations forecast expenditure per head, 2005-2010 (UYU, 2005 prices) 67 Table 61: Uruguay Cough and cold preparations expenditure per head, 2000-2005 (US$ nominal prices) 68 Table 62: Uruguay Cough and cold preparations forecast expenditure per head, 2005-2010 (US$ nominal prices) 68 Table 63: Uruguay Cough and cold preparations value, by age group, 2005 69 Table 64: Uruguay Cough and cold preparations value, by income group, 2005 69 Table 65: Uruguay Cough and cold preparations value, by gender, 2005 70 Table 66: Uruguay Cough and cold preparations value, by marital status, 2005 70 Table 67: Uruguay Cough and cold preparations value, by size of household, 2005 71 Table 68: Uruguay Cough and cold preparations value, by urban/rural residence, 2005 71 Table 69: Uruguay Indigestion preparations value, 2000-2005 (UYU m, 2005 prices) 72 Table 70: Uruguay Indigestion preparations value forecast, 2005-2010 (UYU m, 2005 prices) 72 Table 71: Uruguay Indigestion preparations value, 2000-2005 (UYU m, nominal prices) 74 Table 72: Uruguay Indigestion preparations value forecast, 2005-2010 (UYU m, nominal prices) 74 Table 73: Uruguay Indigestion preparations value, 2000-2005 (US$ m nominal prices) 75 Table 74: Uruguay Indigestion preparations value forecast, 2005-2010 (US$ m nominal prices) 75 Table 75: Uruguay Indigestion preparations brand share, by value, 2004-2005 (%) 77 Table 76: Uruguay Indigestion preparations value, by brand, 2004-2005 (UYU m nominal prices) 77 Table 77: Uruguay Indigestion preparations company share, by value, 2004-2005 (%) 78 Table 78: Uruguay Indigestion preparations value, by company, 2004-2005 (UYU m nominal prices) 78 Table 79: Uruguay Indigestion preparations distribution channels, by value, 2004-2005 (%) 79 Table 80: Uruguay Indigestion preparations value, by distribution channel, 2004-2005 (UYU m nominal prices) 79 Table 81: Uruguay Indigestion preparations expenditure per head, 2000-2005 (UYU, 2005 prices) 80 Table 82: Uruguay Indigestion preparations forecast expenditure per head, 2005-2010 (UYU, 2005 prices) 80 Table 83: Uruguay Indigestion preparations expenditure per head, 2000-2005 (US$ nominal prices) 81 Table 84: Uruguay Indigestion preparations forecast expenditure per head, 2005-2010 (US$ nominal prices) 81 Table 85: Uruguay Indigestion preparations value, by age group, 2005 82 Table 86: Uruguay Indigestion preparations value, by income group, 2005 82 Table 87: Uruguay Indigestion preparations value, by gender, 2005 83 Table 88: Uruguay Indigestion preparations value, by marital status, 2005 83 Table 89: Uruguay Indigestion preparations value, by size of household, 2005 84 Table 90: Uruguay Indigestion preparations value, by urban/rural residence, 2005 84 Table 91: Uruguay Medicated skin products value, 2000-2005 (UYU m, 2005 prices) 85 Table 92: Uruguay Medicated skin products value forecast, 2005-2010 (UYU m, 2005 prices) 86 Table 93: Uruguay Medicated skin products value, 2000-2005 (UYU m, nominal prices) 88 Table 94: Uruguay Medicated skin products value forecast, 2005-2010 (UYU m, nominal prices) 88 Table 95: Uruguay Medicated skin products value, 2000-2005 (US$ m nominal prices) 89 Table 96: Uruguay Medicated skin products value forecast, 2005-2010 (US$ m nominal prices) 89 Table 97: Uruguay Medicated skin products brand share, by value, 2004-2005 (%) 91 Table 98: Uruguay Medicated skin products value, by brand, 2004-2005 (UYU m nominal prices) 91 Table 99: Uruguay Medicated skin products company share, by value, 2004-2005 (%) 92 Table 100: Uruguay Medicated skin products value, by company, 2004-2005 (UYU m nominal prices) 92 Table 101: Uruguay Medicated skin products distribution channels, by value, 2004-2005 (%) 93 Table 102: Uruguay Medicated skin products value, by distribution channel, 2004-2005 (UYU m nominal prices) 93 Table 103: Uruguay Medicated skin products expenditure per head, 2000-2005 (UYU, 2005 prices) 94 Table 104: Uruguay Medicated skin products forecast expenditure per head, 2005-2010 (UYU, 2005 prices) 95 Table 105: Uruguay Medicated skin products expenditure per head, 2000-2005 (US$ nominal prices) 96 Table 106: Uruguay Medicated skin products forecast expenditure per head, 2005-2010 (US$ nominal prices) 96 Table 107: Uruguay Medicated skin products value, by age group, 2005 97 Table 108: Uruguay Medicated skin products value, by income group, 2005 97 Table 109: Uruguay Medicated skin products value, by gender, 2005 98 Table 110: Uruguay Medicated skin products value, by marital status, 2005 98 Table 111: Uruguay Medicated skin products value, by size of household, 2005 99 Table 112: Uruguay Medicated skin products value, by urban/rural residence, 2005 99 Table 113: Uruguay Traditional medicines value, 2000-2005 (UYU m, 2005 prices) 100 Table 114: Uruguay Traditional medicines value forecast, 2005-2010 (UYU m, 2005 prices) 100 Table 115: Uruguay Traditional medicines value, 2000-2005 (UYU m, nominal prices) 102 Table 116: Uruguay Traditional medicines value forecast, 2005-2010 (UYU m, nominal prices) 102 Table 117: Uruguay Traditional medicines value, 2000-2005 (US$ m nominal prices) 103 Table 118: Uruguay Traditional medicines value forecast, 2005-2010 (US$ m nominal prices) 103 Table 119: Uruguay Traditional medicines brand share, by value, 2004-2005 (%) 104 Table 120: Uruguay Traditional medicines value, by brand, 2004-2005 (UYU m nominal prices) 104 Table 121: Uruguay Traditional medicines company share, by value, 2004-2005 (%) 105 Table 122: Uruguay Traditional medicines value, by company, 2004-2005 (UYU m nominal prices) 105 Table 123: Uruguay Traditional medicines distribution channels, by value, 2004-2005 (%) 106 Table 124: Uruguay Traditional medicines value, by distribution channel, 2004-2005 (UYU m nominal price) 106 Table 125: Uruguay Traditional medicines expenditure per head, 2000-2005 (UYU, 2005 prices) 107 Table 126: Uruguay Traditional medicines forecast expenditure per head, 2005-2010 (UYU, 2005 prices) 107 Table 127: Uruguay Traditional medicines expenditure per head, 2000-2005 (US$ nominal prices) 108 Table 128: Uruguay Traditional medicines forecast expenditure per head, 2005-2010 (US$ nominal prices) 108 Table 129: Uruguay Traditional medicines value, by age group, 2005 109 Table 130: Uruguay Traditional medicines value, by income group, 2005 109 Table 131: Uruguay Traditional medicines value, by gender, 2005 110 Table 132: Uruguay Traditional medicines value, by marital status, 2005 110 Table 133: Uruguay Traditional medicines value, by size of household, 2005 111 Table 134: Uruguay Traditional medicines value, by urban/rural residence, 2005 111 Table 135: Uruguay Vitamins and minerals value, 2000-2005 (UYU m, 2005 prices) 112 Table 136: Uruguay Vitamins and minerals value forecast, 2005-2010 (UYU m, 2005 prices) 113 Table 137: Uruguay Vitamins and minerals value, 2000-2005 (UYU m, nominal prices) 115 Table 138: Uruguay Vitamins and minerals value forecast, 2005-2010 (UYU m, nominal prices) 115 Table 139: Uruguay Vitamins and minerals value, 2000-2005 (US$ m nominal prices) 116 Table 140: Uruguay Vitamins and minerals value forecast, 2005-2010 (US$ m nominal prices) 116 Table 141: Uruguay Vitamins and minerals brand share, by value, 2004-2005 (%) 118 Table 142: Uruguay Vitamins and minerals value, by brand, 2004-2005 (UYU m nominal prices) 118 Table 143: Uruguay Vitamins and minerals company share, by value, 2004-2005 (%) 119 Table 144: Uruguay Vitamins and minerals value, by company, 2004-2005 (UYU m nominal prices) 119 Table 145: Uruguay Vitamins and minerals distribution channels, by value, 2004-2005 (%) 120 Table 146: Uruguay Vitamins and minerals value, by distribution channel, 2004-2005 (UYU m nominal price) 120 Table 147: Uruguay Vitamins and minerals expenditure per head, 2000-2005 (UYU, 2005 prices) 121 Table 148: Uruguay Vitamins and minerals forecast expenditure per head, 2005-2010 (UYU, 2005 prices) 121 Table 149: Uruguay Vitamins and minerals expenditure per head, 2000-2005 (US$ nominal prices) 122 Table 150: Uruguay Vitamins and minerals forecast expenditure per head, 2005-2010 (US$ nominal prices) 122 Table 151: Uruguay Vitamins and minerals value, by age group, 2005 123 Table 152: Uruguay Vitamins and minerals value, by income group, 2005 123 Table 153: Uruguay Vitamins and minerals value, by gender, 2005 124 Table 154: Uruguay Vitamins and minerals value, by marital status, 2005 124 Table 155: Uruguay Vitamins and minerals value, by size of household, 2005 125 Table 156: Uruguay Vitamins and minerals value, by urban/rural residence, 2005 125 Table 157: Uruguay Other OTC healthcare value, 2000-2005 (UYU m, 2005 prices) 126 Table 158: Uruguay Other OTC healthcare value forecast, 2005-2010 (UYU m, 2005 prices) 126 Table 159: Uruguay Other OTC healthcare value, 2000-2005 (UYU m, nominal prices) 128 Table 160: Uruguay Other OTC healthcare value forecast, 2005-2010 (UYU m, nominal prices) 128 Table 161: Uruguay Other OTC healthcare value, 2000-2005 (US$ m nominal prices) 129 Table 162: Uruguay Other OTC healthcare value forecast, 2005-2010 (US$ m nominal prices) 129 Table 163: Uruguay Other OTC healthcare brand share, by value, 2004-2005 (%) 130 Table 164: Uruguay Other OTC healthcare value, by brand, 2004-2005 (UYU m nominal prices) 130 Table 165: Uruguay Other OTC healthcare company share, by value, 2004-2005 (%) 131 Table 166: Uruguay Other OTC healthcare value, by company, 2004-2005 (UYU m nominal prices) 131 Table 167: Uruguay Other OTC healthcare distribution channels, by value, 2004-2005 (%) 132 Table 168: Uruguay Other OTC healthcare value, by distribution channel, 2004-2005 (UYU m nominal prices) 132 Table 169: Uruguay Other OTC healthcare expenditure per head, 2000-2005 (UYU, 2005 prices) 133 Table 170: Uruguay Other OTC healthcare forecast expenditure per head, 2005-2010 (UYU, 2005 prices) 133 Table 171: Uruguay Other OTC healthcare expenditure per head, 2000-2005 (US$ nominal prices) 134 Table 172: Uruguay Other OTC healthcare forecast expenditure per head, 2005-2010 (US$ nominal prices) 134 Table 173: Uruguay Other OTC healthcare value, by age group, 2005 135 Table 174: Uruguay Other OTC healthcare value, by income group, 2005 135 Table 175: Uruguay Other OTC healthcare value, by gender, 2005 136 Table 176: Uruguay Other OTC healthcare value, by marital status, 2005 136 Table 177: Uruguay Other OTC healthcare value, by size of household, 2005 137 Table 178: Uruguay Other OTC healthcare value, by urban/rural residence, 2005 137 Table 179: Uruguay population, by age group, 2000-2005 (millions) 138 Table 180: Uruguay population forecast, by age group, 2005-2010 (millions) 139 Table 181: Uruguay population, by gender, 2000-2005 (millions) 139 Table 182: Uruguay population forecast, by gender, 2005-2010 (millions) 140 Table 183: Uruguay real GDP, 2000-2005 (BRL bn, 2005 prices) 140 Table 184: Uruguay real GDP forecast, 2005-2010 (BRL bn, 2005 prices) 140 Table 185: Uruguay nominal GDP, 2000-2005 (BRL bn, nominal prices) 141 Table 186: Uruguay nominal GDP forecast, 2005-2010 (BRL bn, nominal prices) 141 Table 187: Uruguay real GDP, 2000-2005 (US$ bn, 2005 prices) 141 Table 188: Uruguay real GDP forecast, 2005-2010 (US$ bn, 2005 prices) 142 Table 189: Uruguay consumer price index, 2000-2005 (2000=100) 142 Table 190: Uruguay consumer price index, 2005-2010 (2000=100) 142 Table 191: Uruguay exchange rate, 2000-2005 143 List of Figures Figure 1: Uruguay OTC Healthcare value & value forecast, 2000-2010 (UYU m, 2005 prices) 27 Figure 2: Uruguay OTC Healthcare category growth comparison, by value, 2000-2010 32 Figure 3: Uruguay Analgesics value & value forecast, 2000-2010 (UYU m, 2005 prices) 45 Figure 4: Uruguay Analgesics segment growth comparison, by value, 2000-2010 48 Figure 5: Uruguay Cough and cold preparations value & value forecast, 2000-2010 (UYU m, 2005 prices) 59 Figure 6: Uruguay Cough and cold preparations segment growth comparison, by value, 2000-2010 62 Figure 7: Uruguay Indigestion preparations value & value forecast, 2000-2010 (UYU m, 2005 prices) 73 Figure 8: Uruguay Indigestion preparations segment growth comparison, by value, 2000-2010 76 Figure 9: Uruguay Medicated skin products value & value forecast, 2000-2010 (UYU m, 2005 prices) 87 Figure 10: Uruguay Medicated skin products segment growth comparison, by value, 2000-2010 90 Figure 11: Uruguay Traditional medicines value & value forecast, 2000-2010 (UYU m, 2005 prices) 101 Figure 12: Uruguay Vitamins and minerals value & value forecast, 2000-2010 (UYU m, 2005 prices) 114 Figure 13: Uruguay Vitamins and minerals segment growth comparison, by value, 2000-2010 117 Figure 14: Uruguay Other OTC healthcare value & value forecast, 2000-2010 (UYU m, 2005 prices) 127 Figure 15: Annual data review process 145
|
|
|
PPLSEN
|
|
|
|
|